“…Silei et al, 2000;Fagerstrom et al, 1996), but there is still some controversy for the contribution of other nPKCs, namely PKC and . PKC , expressed occasionally in NB cells or tumors (Zeidman et al, 1999b), may contribute to apoptotic pathways in SK-N-BE(2) and SH-SY5Y cells (Schultz & Larsson, 2004;Schultz et al, 2003). Unlike , is commonly expressed (Zeidman et al, 1999b), yet again, transfection studies with full-length, catalytically inactive, or active PKC variants have revealed a pro-apoptotic role (Schultz et al, 2003;Schultz & Larsson, 2004).…”